Filing search / Intra-Cellular Therapies, Inc. / "Opioid" / Page 2

8-K

EX-99.1

l5hvqb

9 Aug 22

Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

7:38am

8-K

EX-99.1

8h46erdj

10 May 22

Intra-cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

7:37am

8-K

EX-99.1

21ojb3a

1 Mar 22

Intra-cellular Therapies Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Corporate Update

7:49am

424B5

kln18wd fme4s

5 Jan 22

Prospectus supplement for primary offering

4:51pm

8-K

EX-99.2

f0wlq

4 Jan 22

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

12:00am

424B5

a92ls02g fh

3 Jan 22

Prospectus supplement for primary offering

5:30pm

8-K

EX-99.1

gazl8c

9 Nov 21

Intra-cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

7:49am

8-K

EX-99.1

2ny9gxezntd81z

9 Aug 21

Intra-cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update

7:37am

8-K

EX-99.1

vrwppr3hnykfhbonhm

10 May 21

Intra-cellular Therapies Reports First Quarter 2021 Financial Results and Provides Corporate Update

7:37am

PRE 14A

4w1m8 s2wmgg4guy5

19 Apr 21

Preliminary proxy

5:28pm

8-K

EX-99.1

po1rkoe01acpn5a27l

25 Feb 21

Intra-cellular Therapies Reports Fourth Quarter and Full-year 2020 Financial Results and Provides Corporate Update

7:54am